Photo via The Guardian

US surgeon general nominee made $270,000 from supplement company

Read the original at The Guardian ↗
Cite

Smith, M. R. (2026, September 15). US surgeon general nominee made $270,000 from supplement company. The Guardian. https://www.theguardian.com/us-news/2026/sep/15/nicole-saphier-supplement-sales-surgeon-general-nominee

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

The Guardian · collected 2026-09-15 · by Michelle R Smith

Quick Summary

Dr. Nicole Saphier, nominated by President Trump to be US surgeon general, reported earning over $270,000 from her dietary supplement company Empower MD, LLC. Critics are concerned about potential conflicts of interest given the loosely regulated nature of the supplement industry and Dr. Saphier's investments in other health-related industries like tobacco, which surgeons general typically warn against. She faces a Senate confirmation hearing amid these concerns and has stated she will sell her company before taking office if confirmed.
Written by AI on 2026-09-16, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Dr Nicole Saphier, Trump's nominee for US surgeon general, has faced scrutiny due to financial disclosures showing she earned over $270,000 from her dietary supplement company Drop RX. The company operates within a loosely regulated industry that some health advocates view with skepticism. Additionally, Saphier reported significant investments in tobacco and other industries affecting public health. As a radiologist specializing in breast cancer at Memorial Sloan Kettering Cancer Center, she is scheduled for Senate confirmation hearings on Wednesday amid these concerns about her financial interests. Critics argue the involvement of dietary supplements could pose conflicts of interest given their often questionable effectiveness and regulation.

Written for “Senate Confirmation Hearing Controversy” on 2026-11-01, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Senate Confirmation Hearing Controversy
Politics · 1 article(s) covering the same event.

Compared with similar articles

This article reads leans left and hedges 4% of its claims. Each row says how that neighbour differs.
The Independent
Hedges 3 of 18 claims Outlet record 59/100
“The articles cover different aspects of Dr. Nicole Saphier's nomination process, with one focusing on her financial disclosure and the other on a Senate confirmation hearing regarding childhood vaccines.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
27
sentences that state something as happening or true
Uncertain
4%
1 of 27 hedged ("reportedly", "may", "according to")
Leaning
Leans left
of the writing, not the subject · beta estimate
Publisher signals
66/100
The Guardian's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-16 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

The Guardian · 1869 article(s) · 6 correction(s) detected
Running correction rate · 6 correction(s)

Who wrote this

Michelle R Smith
2 article(s) here · 1 carrying a prediction
🔮 The deputy director and chief medical officer of the Centers for Disease Control and Prevention (CDC) will resign after six months on the job, according to an agency email obtained by the Guardian.
🔮 She said she would sell the company before assuming the duties of surgeon general.
Also by Michelle R Smith
Nothing else under this byline is closely related to this article, so these are simply their most recent.

Topics

Drop RX Empower MD Fox News Memorial Sloan Kettering Cancer Center New Jersey

Subjects

Saphier PERSON · 9× Lurie PERSON · 3× Empower MD ORG · 2× Maha PERSON · 2× Donald Trump’s PERSON · 1× Fox News ORG · 1× Memorial Sloan Kettering Cancer Center ORG · 1× New Jersey GPE · 1× Nicole Saphier PERSON · 1× Senate ORG · 1×

Narrative

Spokesman Kush Desai previously said that Saphier “is an accomplished physician who has practiced radiology at Memorial Sloan-Kettering and has been an outspoken voice on breast cancer prevention, intrusive Covid-19 mandates, the politicization of science, and the federal government’s role in America’s chronic disease epidemic.”
framing: assertive · carried by 1 article(s) · first seen 2026-09-16
🔮 She said she would sell the company before assuming the duties of surgeon general.
2026-09-16 · The Guardian
US surgeon general nominee made $270,000 from supplement company · assertive framing

Claims (27 extracted, 1 hedged)

Donald Trump’s nominee for US surgeon general reported more than $200,000 in business income from a company she owns that sells dietary supplements, a loosely regulated industry that health and consumer advocates say raises concerns about her record and which some critics allege are akin to “snake oil”. asserted
critics → report → oil
Dr Nicole Saphier, who specializes in breast cancer as a radiologist at Memorial Sloan Kettering Cancer Center in New Jersey and was formerly a Fox News contributor, is facing a Senate confirmation hearing on Wednesday. asserted
who → specialize → Wednesday
She filed a financial disclosure and ethics agreement last week. asserted
She → file → agreement
In them, Saphier also reported extensive investments in other industries that have a bearing on Americans’ health, including tobacco. asserted
that → report → tobacco
US surgeons general have warned repeatedly about the dangers of tobacco in dozens of reports since the 1960s. asserted
surgeons → warn → 1960s
Saphier also listed investments in pharmaceutical and healthcare companies, technology, fossil fuel and food companies including Coca-Cola, PepsiCo and McDonald’s. asserted
Saphier → list → Cola
The filings show Saphier made substantial income from her company Empower MD, LLC, which owns her supplement line, Drop RX. asserted
which → show → line
She reported that she received $270,605 in business income from Empower MD and placed the company’s value in a range of $100,001 – $250,000. asserted
she → report → 100,001
She said she would sell the company before assuming the duties of surgeon general. asserted
she → say → surgeon
The Guardian previously reported that Saphier’s company had sold at least nine formulations under the brand name Drop RX since at least 2024 and promoted the products multiple times on her Instagram account. asserted
company → report → account
The company sold several of the 2-ounce liquid formulations on Amazon, packaged in glass bottles with a dropper. asserted
company → sell → dropper
While most are no longer available for sale this week, at least one – a blend that includes turmeric and ginger root and marketed under the name “Soothe” – was being sold for $24.99 as of Monday. asserted
that → include → Monday
A White House spokesperson did not respond to a request for comment. asserted
spokesperson → respond → comment
Spokesman Kush Desai previously said that Saphier “is an accomplished physician who has practiced radiology at Memorial Sloan-Kettering and has been an outspoken voice on breast cancer prevention, intrusive Covid-19 mandates, the politicization of science, and the federal government’s role in America’s chronic disease epidemic.” asserted
who → say → epidemic
He said she would be a “powerful asset for President Trump and work tirelessly to deliver on every facet of his Maha agenda”. asserted
she → say → agenda
Empower MD did not respond to emails seeking comment. asserted
MD → respond → comment
Public health advocates have raised concern about Dr Saphier’s supplement business. asserted
advocates → raise → business
One of Drop RX’s products includes kava kava root, which is listed as a prohibited dietary supplement by the US military. asserted
which → include → military
The US Food and Drug Administration (FDA) has expressed concerns about liver damage associated with kava use and in 2020 published a 29-page review of the scientific literature in which it highlighted safety concerns about it. asserted
it → express → it
“The question is what kind of person invests in supplements or runs a supplement company in the first place” given that such products are not known for being supported by rigorous scientific research, said Dr Peter Lurie, of the Center for Science in the Public Interest. asserted
Lurie → invest → Interest
Lurie has been an outspoken critic of the wellness industry and what he has called “grifters” selling supplements in health secretary Robert F Kennedy Jr’s Make America Healthy Again (Maha) movement. asserted
America → call → movement
But more concerning, Lurie said, was Saphier’s investments in tobacco. asserted
investments → say → tobacco
Saphier reported that both she and her husband hold investments in the tobacco company Philip Morris International, while her husband owns shares of British American Tobacco Industries. asserted
husband → report → Industries
In an ethics agreement, Saphier wrote that she would divest her interests in both companies within 90 days of her confirmation. asserted
she → write → confirmation
Lurie said it was unimaginable that someone could be surgeon general who had tied their own financial interests to increased sales of a product that the surgeon general’s office itself had declared deadly. uncertain
office → say → product
“No public health person worth their salt would put a penny in a tobacco company,” Lurie said. asserted
Lurie → put → company
Saphier is Trump’s third pick for the job after his first two failed to advance in the Senate. asserted
two → fail → Senate
💬Give feedback
🕘History 🎫Support